Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Bullboard Posts
Comment by miningfundion Feb 04, 2019 8:32pm
272 Views
Post# 29318175

RE:Revenue Growth 38.9%

RE:Revenue Growth 38.9%At the current share price, the EV/2018 EBITDA ratio is about 10.0. A more reasonable ratio of 15 suggests a share price of about $9.00. A 15 times ratio of the assumed 2019 run rate EBITDA, suggests a price of about $10.50. Sounds like a reasonable short-term target.
MBA wrote: 2018 vs 2017 and better yet, EBITDA growth of 43% (2018 vs 2017). Revenue year end run rate of $73.7 million (US) and $98 million (Canadian). So clearly, Q1 will put VMD over $100 million (Canadian) and close to $100 million US by the end of 2019. EBITDA numbers this quarter were very impressive. Hopefully, management can hold and build on these numbers as the year end EBITDA run rate is now $19.86 million (US) and $26.5 million Canadian (about 70 cents per share). Now give us the VA deal!!!!


Bullboard Posts